Parkinsonism What makes it different?



Similar documents
III./ Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases

PARKINSONISM. akinetic-rigid syndrome

NEUROIMAGING in Parkinsonian Syndromes

Parkinson s Disease - A Junior Doctor s Survival Guide

Dementia & Movement Disorders

PARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB

Management of Parkinson s Disease in Primary Care

Multiple System Atrophy

Prevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Parkinson s Disease and Dementia. Dr N Samaniego Consultant Physician and Geriatrician

Clinical Psychopharmacology

GLOSSARY OF TERMS. This glossary explains the terms and words often used in association with Parkinson s.

Emergency Room Treatment of Psychosis

Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses. 26 April 2013

Neurodegenerative Diseases

Doctor I can t walk properly - a guided walk around some gait problems

Cerebellum and Basal Ganglia

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

Motor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia

Anti-Parkinsonism Drugs

Parkinson s Disease (PD)

Chapter 28. Drug Treatment of Parkinson s Disease

2016 Programs & Information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Motor Pathway

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

Meeting Report: XX WFN World Congress on Parkinson s Disease and Related Disorders

Parkinson's s disease - a

An Introduction to Lewy Body Dementia

How to test ocular movements in PSP Jan Kassubek

Neurological System Best Practice Documentation

Movement Disorders: Diagnosis i and Treatment. Movement Disorders: Classification

Parkinson s Disease Symptoms Guide

Journal Club. Parkinsonismo iatrogeno

Dementia Causes and Neuropsychological Evaluation of the Older Adult


What Every... Should Know About: Social Worker Physical Therapist Occupational Therapist Speech-Language Pathologist

Neurology Clerkship Learning Objectives

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Disorders Considered. A Brief Synopsis of Select Neurological Disorders. Neurological and Psychiatric Symptoms. Neurological Basis

Parkinson s Disease: A Review of Motor and Nonmotor Symptoms

Parkinson-Plus Syndromes

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Multiple Sclerosis: An imaging review and update on new treatments.

ICD-9-CM coding for patients with Traumatic Brain Injury*

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation

Personal Health Record

CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE

Chapter 3 The Anatomy of the Nervous System

Multiple System Atrophy guide (

2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives

Multiple System Atrophy: What You Need to Know

Movement Disorders and Extrapyramidal System. Doç.. Dr. Sibel Ertan

What Is Dementia? Type of Dementia

Chapter 7: The Nervous System

SLEEP AND PARKINSON S DISEASE

UNIVERSITY OF FLORIDA

Idiopathic parkinsonism: Epidemiology and clinical characteristics of a populationbased incidence cohort

NEUROLOCALIZATION MADE EASY

How To Treat An Elderly Patient

Basal Ganglia. Motor systems

Developmental delay and Cerebral palsy. Present the differential diagnosis of developmental delay.

Martin Jackson. August 2011

Management in the pre-hospital setting

DIAGNOSTIC CRITERIA OF STROKE

ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis

Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of

Sheep Brain Dissection

3) Cerebral Cortex & Functions of the 4 LOBES. 5) Cranial Nerves (Nerves In the Cranium, i.e., Head)

Mini-atlas of the Marmoset Brain

Transcription:

What is Parkinsonism? Parkinsonism What makes it different? Praween Lolekha, MD. MSc. Neurology division, Department of Internal Medicine Thammasat University A motor syndrome with the following cardinal features: Bradykinesia Rest tremor Rigidity Postural instability Flexed posture Freezing or motor blocks Definite 2/6 Probable 1/6 Possible 2/6 Differential diagnosis of Parkinsonism Red flags for Parkinsonism Idiopathic Parkinson s Disease (PD) Secondary parkinsonism - Drug-induced - Vascular parkinsonism - Normal pressure hydrocephalus (NPH) - CNS infection - Metabolic-toxic encephalopathy - Structural lesions - Head trauma Parkinsonism Parkinson-plus syndrome - Progressive supranuclear palsy (PSP) - Corticobasal dengeneration (CBD) - Multiple system atrophy (MSA) - Diffuse Lewy body disease (DLB) Heredodegenerative parkinsonism - Huntington s disease - Wilson s disease (WD) - Neuroacanthocytosis - Neurodegeneration with brain iron accumulation (NBIA) - Spinocerebellar ataxias (2,3,17) - Others Young-onset : Juvenile (genetic) PD Wilson s disease (WD), NBIA Symmetric onset: MSA, PSP, VaP, NPH Absent tremor : Ataxia : MSA, PSP, CBD, VaP, NPH MSA, SCA Pyramidal signs : MSA, PSP, CBD, VaP, NPH Neuropathy : MSA Early postural instability: PSP, MSA, VaP, NPH Red flags for Parkinsonism Secondary Parkinsonism Myoclonus : CBD, CJD Dementia : DLB, AD, CJD, PSP, VaD Psychotic symptoms: DLB, AD Focal cortical signs : CBD Alien limb sign: CBD Oculomotor deficits : PSP Dysautonomia : MSA Non-response to levodopa: MSA, CBD, PSP, VaD, etc. Drug-induced parkinsoism Normal pressure hydrocephalus (NPH) Cerebrovascular disease Toxins Trauma 1

Drug-induced parkinsonism Drug-induced parkinsonism Most common cause of 2nd parkinsonism Dopamine blocking agents Signs & Symptoms Symmetrical onset Action and postural tremor: upper limbs, oral Gradual and progressive (1-3 months) Improve after discontinue drugs (may take as long as 18 months) Cerebrovascular parkinsonism Lower body parkinsonism 3-12% of parkinsonism Arteriosclerosis risk factors Multi-infarct parkinsonism Lower body parkinsonism No definite diagnosis criteria Parkinsonism with evidence of cerebrovascular disease Acute (1 month), progressive (1 year) onset with lesions at basal ganglia, thalamus, substantia nigra after a stroke Extensive subcortical white-matter lesions Most common type of vascular parkinsonism Gait freezing, start hesitation Wide-base shuffling gait Normal upper extremities No tremor Not response to levodopa treatment Dementia, pseudobulbar palsy Normal Pressure Hydrocephalus Toxic induced parkinsonism Gait apraxia Subcortical dementia Urinary incontinence Fisher s test: removing 30-50cc of CSF and observing for improvement in symptoms over the next 24 hours (100% specificity, 30% sensitivity) Predict response to ventriculoperitoneal shunt 2

Infectious and parkinsonism Encephalitis lethargica Von-Economo s disease, 1917-1927 No recurrence of the epidemic has since been reported Fever, sore throat, headache, myalgia Somnolent opthalmoplegia, sleepy sickness Parkinsonism, catatonia, akinetic mutism 40% mortality, 60% morbidity Unknown cause: post viral infection, Influenza? Autoimmune: steptococcus gr. A infection? Parkinson-plus syndrome Striatonigral degeneration : MSA-P Shy-Drager syndrome : MSA-A Olivopontocerebellar atrophy: MSA-C Pathology: Glia cytoplasmic inclusion (GCIs) GCIs + gliosis Basal ganglia Cerebellum Pons Inferior olivary nuclei Spinal cord Prevalence 1-5/100,000 Age onset 40-60 years old Prognosis ~10 years MSA-P: common in western MSA-C: common in Asia Late stage 28% have all symptoms Cytoplasmic αs-containing inclusions in oligodendroglia 3

Autonomic (at least 1 symptom) Orthostatic hypotension 30mmHg systolic, 15mmHg diastolic 3 minutes Syncope, light-headedness, dizziness Erectile dysfunction Urinary incontinence Constipation Cold-hand sign Parkinsonism Akinetic rigidity Postural tremor, myoclonus May be asymmetrical involvement Orofacial dystonia Anterocollis Laryngeal dystonia (inspiratory stridor) Cerebellar symptoms Gait ataxia --> limb ataxia (late) Scanning + spastic dysarthria Dysmetric saccade Gaze-evoked nystagmus Disequilibrium Early gait disorder, wide-based gait Pyramidal symptoms Hyperreflexia Spastic dystonia Extensor plantar response Pseudobulbar palsy REM sleep behavior disorder Obstructive Sleep Apnea (OSA) Pisa syndrome Transverse pontine fibers degeneration Hyposignal in putamen with slit like Hyperintense (iron deposit) 4

Early response to levodopa 40%, < 2 years Prevent complication Laryngeal dystonia Orthostatic hypotension Fluid intake, high salt diet Elastic body garments Head-up at night Fludrocortisone (0.1-0.3mg/day) Dystonia- Botulinum toxin injection Steele-Richardson-Olszewski syndrome Most common parkinson-plus syndrome Prevalence 6-6.4/100,000 Onset 60-70 years old Prognosis ~10 years Macroscopic pathology Subthalamic nucleus Red nucleus Substantia nigra Pontine tegmentum Striatum Oculomotor nucleus Medulla Dentate nucleus Tufted astrocyte Tau +ve Neurofibrillary tangle Atrophy of midbrain tectum, tecmentum Atrophy of superior colliculi Dilate third ventricle Hypersignal periaqueductal gray, red nucleus, midbrain Richardson s syndrome (Classic PSP) PSP-parkinsonism (PSP-P) (30%) PSP-pure akinesia with gait freezing (PSP-PAGF) PSP-corticobasal syndrome (PSP-CBS) PSP-progressive non-fluent aphasia (PSP-PNFA) Parkinsonism: symmetrical Early postural instability: backward falls Axial>limb rigidity Cervical dystonia: retrocollis Facial dystonia: procerus sign Mild postural, action tremor Frontal lobe dysfunction: apathy, disinhibition (applause sign) 5

PSP-Imaging study Extraocular movement Slow vertical saccades: first eye sign Vertical gaze palsy : down-> up-> horizontal which corrected by VOR Decreased nystagmus in optokinetic testing Decrease eye blink Eyelid opening apraxia Penguin sign Morning glory sign Corticobasal Syndrome (CBS) and Corticobasal Degeneration (CBD) Levodopa response ~10-30% in the first 2 years Gait training Prevent falls Botulinum toxin injection +/- Anticholinergic - Dopamine agonists Co enzyme Q10 Cortex + Basal ganglia pathology Corticobasal syndrome (CBS: clinical phenotype) CBD, AD, Pick s disease, PSP, FTD, CJD, PML Corticobasal degeneration (CBD: pathology) Age onset: 60-70 years old Hyperphosphorylated tau The least common parkinson-plus Corticobasal Syndrome (CBS) Corticobasal Syndrome (CBS) Parkinsonism Levodopa-resistant parkinsonism Asymmetric akinetic rigid syndrome Limb clumsiness Limb dystonia Action tremor, myoclonus Postural instability and falls Fisted hand sign Cortical lobe signs Apraxia : limb apraxia, ideomotor apraxia, limbkinetic apraxia, orobuccal apraxia, apraxial of eyelid opening Aphasia, mutism Alien limb (50%) Cortical sensory loss, visual neglect Dementia Disinhibition, agitation, depression, anxiety 6

Corticobasal degeneration (CBD) Tau-positive ballooned neuron Asymmetry cortical atrophy Astrocytic plagues Tau accumulation in Cortex Basal ganglia Thalamus Brainstem Dementia with Lewy Bodies (DLB) Levodopa response 20% -Dopamine agonists +Benzodiazepine +Botulinum toxin injection Rx dementia, depression 2nd most common of dementia (15-30%) Mean age 75 years old Dementia: 1 year rule of PDD Fluctuating, visuospatial, attention Parkinsonism: symmetrical onset, no tremor Recurrent visual hallucination: vivid, complex Extreme sensitivity to neuroleptics Cholinesterase inhibitors Rivastigmine Memantine (NMDA receptor antagonist) Atypical antipsychotic drugs Clonzapine, Quetiapine +/- Levodopa - DA/Anticholinergic PD PSP MSA CBD DLB Motor symmetry + +++ +++ - ++ Axial rigidity ++ +++ ++ ++ ++ Tremor +++ - - + + Limb dystonia + + + +++ - Pyramidal signs - + ++ +++ - Apraxia - + - +++ - Postural instability ++ +++ ++ + ++ Vertical supranuclear gaze restriction + +++ ++ ++ - Frontal behavior + +++ + ++ ++ Visual hallucination + - - + +++ Dysautonomia + - ++ - + Levodopa response early in course +++ + + - + Levodopa response late in course ++ - + - + 7